AB vs IVZ

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 01, 2026

AB

50.4
AI Score
VS
IVZ Wins

IVZ

64.7
AI Score

Investment Advisor Scores

AB

50score
Recommendation
HOLD

IVZ

65score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric AB IVZ Winner
Forward P/E 9.3545 9.5147 AB
PEG Ratio 0.6343 0.9008 AB
Revenue Growth -40.3% 20.5% IVZ
Earnings Growth 20.9% 35.0% IVZ
Tradestie Score 50.4/100 64.7/100 IVZ
Profit Margin 390.6% -0.9% AB
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

AB 1M: -4.4% · 3M: -5.0% IVZ 1M: -3.3% · 3M: +10.2%

Current Technical Phase

AB

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.1%), weak momentum, RSI 38

RSI (14): 37.9 · Price: $35.00

IVZ

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.3 · Price: $30.66

Fundamentals Snapshot

Metric AB IVZ
Market Cap — —
Forward P/E 9.3 9.4
Trailing P/E 10.4 —
Revenue (TTM) — —
Revenue Growth -0.4% 0.2%
Gross Margin 1.0% 0.3%
Operating Margin 1.0% 0.2%
EPS 3.36 -0.68
Dividend Yield 0.10% 0.03%

Frequently Asked Questions

Based on our detailed analysis, IVZ is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.